-
Levin Bengtsen posted an update 4 hours, 26 minutes ago
To report the results of a randomized controlled trial comparing outcomes between medium power (MP) and high power (HP) laser settings for HoLEPs.
The primary objective was to compare the enucleation efficiency (EE) of HP- HoLEP (80-100W) with MP-HoLEP (50 - 60W). The secondary objectives were to compare treatment efficacy and safety bet…[Read more]
-
Levin Bengtsen posted an update 1 day, 4 hours ago
Cancer is a multifactorial disease characterized by complex molecular landscape and altered cell pathways that results in an abnormal cell growth. Natural compounds are target-specific and pose a limited cytotoxicity; therefore, can aid in the development of new therapeutic interventions for the treatment of this versatile disease. Berberine is a…[Read more]
-
Levin Bengtsen posted an update 2 days, 4 hours ago
nce in older adults experiencing chronic conditions and taking multiple medications. The technology induces better consistency and improvement in medication taking behaviour than simple, non-technological intervention.
Registered with ClinicalTrials.gov on April 09, 2020 with identifier NCT04339296 .
Registered with ClinicalTrials.gov…[Read more]
-
Levin Bengtsen posted an update 3 days, 4 hours ago
The questionnaire carried out showed that anaesthesia and postoperative care after TAVR are underestimated.
The preliminary results regarding anaesthetic management in TAVR procedures demonstrate that monitored sedation is safe, provided that contraindications are observed.
The preliminary results regarding anaesthetic management in…[Read more]
-
Levin Bengtsen posted an update 3 days, 15 hours ago
Globular glial tauopathy (GGT) is a recently proposed tauopathy characterized by the globular accumulation of four-repeat (4R) tau in the oligodendroglia (globular oligodendroglial inclusion (GOI)) and astrocytes (globular astrocytic inclusion (GAI)), in addition to deposition in neurons. Although it is proposed that GGT should be classified into…[Read more]
-